Solara Active Pharma Sciences Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: SOLARA BSE: 541540

₹725.40

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #68 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Solara Active Pharma Sciences Limited (this stock)	3,500	—	-0.6%	19.8%	—	33	64	53

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹4,111 Cr

EV / EBITDA

21.3x

EV / Sales

2.87x

Market cap / Sales

2.44x

Earnings yield

Data unavailable.

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 384 Cr, up 19.8% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 17 Cr, up 61.3% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	382	17	17	₹3.6700
March 31, 2026	387	10	10	₹2.2300
Dec. 31, 2025	349	-17	-17	₹-3.9700
Sept. 30, 2025	314	-10	-10	₹-2.3600
June 30, 2025	319	11	11	₹2.4600
March 31, 2025	273	-5	-5	₹-1.6500
Sept. 30, 2024	347	8	8	₹2.1100
June 30, 2024	363	-12	-12	₹-3.2000
March 31, 2024	299	-168	-256	₹-71.2300
Dec. 31, 2023	249	-275	-275	₹-76.4900
Sept. 30, 2023	425	-15	-15	₹-4.2400
June 30, 2023	352	-30	-20	₹-5.5200
March 31, 2023	381	8	6	₹1.7900

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	384	392	—	314	320	279	347	365	301	249	426	354	386
Operating revenue	382	387	349	314	319	273	347	363	299	249	425	352	381
Other income	2	4	—	0	1	6	0	1	2	0	1	2	5
Operating expenses	320	330	312	279	262	230	286	321	290	410	388	333	329
Operating profit	62	58	37	35	57	43	61	42	10	-162	38	19	52
Operating profit margin	16.3%	14.9%	10.7%	11.1%	17.9%	15.6%	17.7%	11.6%	3.3%	-65.0%	8.9%	5.4%	13.5%
Depreciation	27	26	26	24	24	24	25	25	25	26	26	26	26
Interest	20	27	22	21	24	29	28	31	31	25	24	26	22
Exceptional items, gain / (loss)	—	1	-7	—	—	—	—	—	-123	-63	-4	—	—
Profit before tax	17	10	-17	-10	11	-5	8	-12	-168	-275	-15	-30	8
Tax	—	—	—	—	—	—	—	—	89	—	—	-10	2
Net profit	17	10	-17	-10	11	-5	8	-12	-256	-275	-15	-20	6
EPS	3.67	2.23	-3.97	-2.36	2.46	-1.65	2.11	-3.20	-71.23	-76.49	-4.24	-5.52	1.79
Net profit (TTM)	-1	-7	-22	4	1	-266	-536	-559	-567	-304	-28	-23	-22
EPS (TTM)	-0.43	-1.64	-5.52	0.56	-0.28	-73.97	-148.81	-155.16	-157.48	-84.46	-7.85	-6.36	-6.17

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	1,369	-7	-7
March 31, 2025	1,284	-1	-1

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Total income (before exceptional items)	—	—	—	—	1,331^†	1,466^†	1,287^†	1,645^†	1,330^†
Operating revenue	-1.8%	-3.3%	1,369	1,284	1,326^†	1,444^†	1,268^†	1,617^†	1,305^†
Other income	—	—	—	—	5^†	22^†	19^†	28^†	26^†
Operating expenses	—	—	1,182^†	—	1,421^†	1,310^†	1,188^†	1,232^†	1,041^†
Operating profit	11.7%	-13.5%	187^†	—	-95^†	134^†	80^†	385^†	264^†
Operating profit margin	—	—	13.6%^†	—	-7.2%^†	9.3%^†	6.3%^†	23.8%^†	20.2%^†
Depreciation	—	—	100^†	—	103^†	111^†	112^†	108^†	90^†
Interest	—	—	94^†	—	106^†	90^†	75^†	84^†	78^†
Exceptional items, gain / (loss)	—	—	-6^†	—	-190^†	0^†	-3^†	0^†	0^†
Profit before tax	—	—	-7	-1	-488^†	-45^†	-92^†	221^†	122^†
Tax	—	—	—	—	—	-23^†	—	—	—
Net profit	—	—	-7	-1	-567^†	-22^†	-59^†	221^†	122^†
EPS	—	—	-1.64^†	—	-157.48^†	-6.17^†	-16.30^†	68.86^†	46.95^†

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Operating margin	13.6%^†	—	-7.2%^†	9.3%^†	6.3%^†	23.8%^†	20.2%^†
EBIT margin	6.4%^†	—	-28.8%^†	3.1%^†	-1.3%^†	18.9%^†	15.3%^†
PBT margin	-0.5%	-0.1%	-36.8%^†	-3.1%^†	-7.2%^†	13.7%^†	9.3%^†
Net margin	-0.5%	-0.1%	-42.8%^†	-1.5%^†	-4.6%^†	13.7%^†	9.3%^†
Interest coverage	0.92x^†	—	-3.61x^†	0.50x^†	-0.22x^†	3.62x^†	2.56x^†
Dividend payout	—	—	—	—	—	8.7%^†	10.6%^†
Earnings retention	—	—	—	—	—	91.3%^†	89.4%^†
Current ratio	0.91x	0.78x	—	—	—	—	—
Quick ratio	0.55x	0.44x	—	—	—	—	—
Debt to equity	0.49x	0.71x	—	—	—	—	—
Return on equity	-0.6%	-0.1%	—	—	—	—	—
Return on assets	-0.3%	0.0%	—	—	—	—	—
Return on capital employed	6.3%^†	—	—	—	—	—	—
Asset turnover	0.60x	0.58x	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	153	-50	-103	53	100
March 31, 2025	213	-37	-180	40	173

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	2,277	1,255	1,211	554	61	809	888	4	787	318
March 31, 2025	2,225	1,096	1,056	662	114	729	938	4	732	318

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.